Imagine falling seriously ill with an infection. Normally, we visit the doctor, are prescribed antibiotics, and after 7-10 days, we're back on our feet.

An international team of researchers has found that an antibiotic commonly prescribed for patients with liver disease, called rifaximin, has led to the global emergence of an almost untreatable form ...

Researchers at Intermountain Health have been awarded a $356,000 grant from Merck, a global science and technology company ...

The annual meeting of the Infectious Diseases Society of America was held this year from Oct. 16 to 19 in Los Angeles, ...

A new study has found that an antibiotic for liver disease patients could expose them to greater risk of a dangerous superbug.

Antimicrobial resistance (AMR) is causing a crisis in hospitals, making antibiotics ineffective against serious infections, leading to higher mortality rates. Experts highlight the rise in ...

The study has demonstrated that rifaximin usage is driving resistance to daptomycin, one of the last effective antibiotics ...

HealthDay News — Treating hospitalized patients with bloodstream infections with antibiotics for 7 days is noninferior to ...

This outbreak was shortly preceded by a significantly high incidence of upper-respiratory infections in the school. Twenty-two Cases of Poliomyelitis, St. Mark's School, May, 1936, by Day of Onset ...

and does not have complications like effusion or respiratory failure. One course will usually be enough to cure your pneumonia. In some cases, you may need more than one course of antibiotics if your ...

More than half of healthy term infants born in the United States are infected with respiratory syncytial virus (RSV) during their first year of life, with significant hospitalization and illness ...